News
Scancell taps into NHS matchmaking service for cancer trial
Scancell is using a new service launched by the NHS to pair patients with suitable clinical trials in a phase 2 trial of its melanoma cancer vaccine.
News
BMS gets another FDA okay for Opdivo/Yervoy combo
Bristol-Myers Squibb has claimed its second FDA approval in just a few days for its Opdivo/Yervoy combination, this time in liver cancer.
News
Approval moves Columvi earlier in DLBCL treatment pathway
Roche has claimed a first-in-class approval in the EU for Columvi in relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
News
Pill that can slow breast cancer cleared for NHS use
AstraZeneca's oral drug Truqap will soon be available for people with advanced breast cancer via the NHS in England, as long as testing is available.
News
At-home tablet now an option for NHS bladder cancer patients
The first targeted drug for a common form of bladder cancer that can be taken at home. J&J's Balversa, has been backed for NHS use.
News
Views & Analysis
Deep Dive
Editor's Picks
Editor's Picks
